If you have neuropathy, you may have come across red light therapy as a possible way to reduce burning, tingling, numbness, or nerve pain. The idea is appealing because it offers a non-drug approach that may be used alongside conventional treatment.
But does red light therapy actually work for neuropathy?
The short answer is that the research is promising, particularly for painful diabetic peripheral neuropathy, but the evidence is still developing. Clinical studies have reported improvements in pain, sensation, and some measures of nerve function. However, the studies have used different wavelengths, treatment doses, devices, and treatment schedules, making it difficult to establish one standard protocol.
Most importantly, current research does not show that red light therapy can cure neuropathy or reliably reverse established nerve damage.
What Is Red Light Therapy for Neuropathy
Red light therapy is commonly used to describe a form of photobiomodulation therapy, or PBM. PBM uses specific wavelengths of non-ionizing light to produce biological effects in cells.
Research on neuropathy has investigated both visible red light and near-infrared light. Commonly studied wavelengths include visible red light around 600 to 700 nm and near-infrared wavelengths extending into the 800 to 1000 nm range.
The goal is not simply to heat the nerves. Instead, researchers believe certain wavelengths can interact with cellular components and influence processes related to energy production, inflammation, oxidative stress, blood flow, and tissue repair.
This distinction is important because not every device marketed as a red light or infrared device delivers the same treatment. Wavelength, irradiance, treatment time, distance from the skin, and total energy delivered can all affect the dose received by tissue.
How Red Light Therapy May Affect Nerves
One proposed mechanism involves mitochondria, which are responsible for producing energy inside cells.
Red and near-infrared light can interact with cellular chromophores, including cytochrome c oxidase. Researchers have proposed that this interaction may influence mitochondrial activity and ATP production while also affecting reactive oxygen species and cellular signaling.
For peripheral nerves, researchers are particularly interested in whether these effects can influence inflammation, circulation, pain signaling, and the body's ability to repair damaged nerve tissue.
However, a plausible biological mechanism does not automatically mean that a treatment works clinically.
This is why human clinical trials are important. Laboratory research can help explain how PBM might work, but controlled clinical studies are needed to determine whether those biological effects translate into meaningful improvements in people with neuropathy.
What the Research Says About Neuropathy
The strongest clinical research so far has focused on diabetic peripheral neuropathy.
A 2023 systematic review of photobiomodulation therapy for diabetic peripheral neuropathy examined eight studies and reported improvements in neuropathic pain and nerve conduction velocity, along with changes in plantar pressure distribution. The authors concluded that PBM showed potential for improving neuropathic symptoms and related functional measures.
However, the evidence was limited by the relatively small number of studies and differences between treatment protocols.
For example, one randomized controlled study investigated red and near-infrared wavelengths in people with diabetic peripheral neuropathy. The treatment protocol used 630 nm and 819 nm light and applied treatment to the feet for 15 minutes three times per week over 12 sessions. The researchers reported improvements in measures including foot sensation.
Another randomized controlled trial published in 2025 included 200 people with type 2 diabetes and peripheral neuropathy. The intervention group received low-level helium-neon laser treatment at 632.8 nm for 10 days, with a reported dose of 3.1 J/cm² for 9 minutes on the dorsal and plantar surfaces of the feet. The study reported improvements in neuropathic pain, vibration perception, and other neuropathy-related measurements compared with the sham treatment group.
More recently, a randomized pilot trial published in July 2026 investigated local photobiomodulation in people with diabetic peripheral neuropathy. The study included 26 participants who received local PBM, PBM combined with intravascular laser irradiation of blood, or sham treatment.
The researchers found that neuropathic pain decreased over the assessment period, with a significant within-group reduction in the local PBM group. However, there was no significant group-by-time interaction showing that PBM was clearly superior to sham treatment. The researchers also noted the small sample size, short follow-up period, baseline differences, and potential placebo effects.
Taken together, these studies provide a reason to continue researching PBM for neuropathy, but they do not establish it as a proven treatment for every type of neuropathy.
Red Light Therapy and Neuropathic Pain
Pain is currently one of the more promising areas of research.
Neuropathic pain is different from ordinary muscle or joint pain. It can include burning, shooting sensations, electric-like pain, pins and needles, or unusual sensitivity to touch.
Several PBM studies have reported reductions in neuropathic pain. The 2023 systematic review found that the studies it analyzed generally reported improvements in neuropathic pain following PBM. The 2025 randomized trial also reported improvements in neuropathic pain following treatment.
The 2026 pilot trial provides more recent evidence, but it also illustrates why the results should be interpreted carefully. Although pain decreased during the study, the researchers did not find a statistically significant difference between the treatment groups and sham group over time. Read the full 2026 study
This means "may help reduce neuropathic pain" is a more defensible conclusion than "treats neuropathy."
A person may experience less pain without the underlying neuropathy being completely resolved. Pain is only one part of the condition, and changes in sensation or nerve function may continue even when symptoms improve.
Red Light Therapy and Nerve Regeneration
Claims about nerve regeneration require more caution.
Current evidence does not establish that red light therapy can reliably regenerate damaged peripheral nerves or reverse established neuropathy.
Researchers are investigating whether photobiomodulation may influence processes involved in nerve repair and regeneration. Some laboratory and animal studies have produced encouraging findings, while some human studies have reported improvements in sensory or nerve-related measurements.
But these findings should not be interpreted as proof that a consumer red light device can restore damaged nerves to their original condition.
For diabetic neuropathy in particular, the American Diabetes Association Standards of Care 2026 states that there is currently no specific treatment that reverses the underlying nerve damage. Management focuses on addressing the underlying causes and risk factors, preventing further complications, and treating symptoms.
This means PBM is better understood as a potential complementary approach rather than a proven nerve-regeneration treatment.
Red Light and Near Infrared Light for Neuropathy
The wavelength of light matters.
Visible red light is generally discussed in the range of approximately 600 to 700 nm, while near-infrared PBM commonly uses wavelengths extending into the 800 to 1000 nm range.
Near-infrared light is particularly interesting for neuropathy research because longer wavelengths can generally penetrate tissue more deeply than visible red light.
However, a longer wavelength is not automatically better.
The biological response depends on several variables, including wavelength, irradiance, treatment duration, energy density, treatment distance, and the tissue being treated.
This is why comparing devices based only on electrical wattage can be misleading.
A device advertised as a 100-watt red light panel does not necessarily provide a more appropriate therapeutic dose than a device with lower electrical power. For PBM, more useful specifications include the actual wavelength and measured irradiance at a stated treatment distance.
The Importance of Irradiance and Treatment Dose
One of the most overlooked factors in red light therapy is dose.
Irradiance describes how much optical power reaches a given area, usually expressed in mW/cm². Energy density, or fluence, describes the amount of energy delivered over an area and is usually expressed in J/cm².
These measurements help determine how much light tissue actually receives.
The clinical studies illustrate why this matters. For example, the 2025 randomized trial used a specific wavelength, treatment time, and reported energy density rather than simply describing the treatment as "red light."
Two devices can use the same 660 nm wavelength but deliver very different amounts of light to the skin. One may require a few minutes of treatment while another may require considerably longer to deliver a similar energy dose.
This means simply knowing that a product uses "red light" is not enough to determine whether it resembles a protocol used in a clinical study.
When evaluating a red light therapy device for neuropathy, look for clearly stated information about wavelength, irradiance, treatment distance, treatment duration, and energy density whenever available.
Can Home Red Light Therapy Help Neuropathy
Home PBM devices are increasingly available in the form of LED panels, wraps, pads, and wearable devices.
The potential advantage is convenience. A home device may allow someone to use light therapy regularly without traveling to a clinic.
But there is an important difference between having access to a red light device and having evidence that the specific device provides a clinically effective treatment.
Many clinical studies use carefully controlled lasers or professional PBM systems. A consumer LED panel does not automatically reproduce the same wavelength, irradiance, treatment area, or energy dose.
If you are considering a home device, check whether the manufacturer provides measurable specifications rather than relying only on general claims such as "deep penetrating infrared" or "professional strength."
A useful specification sheet should ideally identify the wavelengths used and provide irradiance measurements at a defined distance.
Is Red Light Therapy Better Than Medication
There is currently not enough evidence to conclude that red light therapy is better than established medications for neuropathic pain.
For painful diabetic peripheral neuropathy, the American Diabetes Association's 2026 Standards of Care lists gabapentinoids, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, and sodium channel blockers among the initial pharmacological treatment options for neuropathic pain.
The choice depends on the individual, the cause of neuropathy, other health conditions, side effects, and the potential for drug interactions.
PBM may be more appropriately considered as a complementary treatment rather than a replacement for established medical care.
This distinction is especially important for people whose neuropathy is caused by an ongoing condition. Treating symptoms without addressing the underlying cause may not prevent the condition from progressing.
Can Red Light Therapy Help Numbness
Numbness is more complicated than pain.
Some studies have reported improvements in sensory measurements following PBM, including changes in vibration perception and other neurological assessments.
The 2025 randomized trial reported improvements in vibration perception and other neuropathy-related measurements after treatment.
The 2026 pilot trial also reported improvements in selected symptoms, including numbness, although the researchers emphasized that the study was small and did not demonstrate definitive superiority over sham treatment.
These findings do not prove that red light therapy can restore normal sensation in everyone with neuropathy.
If numbness is progressing, affecting balance, or causing you to lose awareness of injuries, medical evaluation is important. Reduced sensation can increase the risk of unnoticed wounds, particularly on the feet.
Red Light Therapy for Different Types of Neuropathy
Not all neuropathy is the same.
Diabetic peripheral neuropathy is currently one of the more studied applications of PBM. However, neuropathy can also result from chemotherapy, physical nerve injury, compression, nutritional deficiencies, alcohol use, certain medications, autoimmune conditions, and other causes.
Evidence from diabetic peripheral neuropathy cannot automatically be applied to every type of nerve damage.
There is emerging research in other forms of neuropathy as well. For example, a 2026 pilot trial called the NEUROLIGHT trial investigated photobiomodulation for chemotherapy-induced peripheral neuropathy.
This distinction matters because different forms of neuropathy have different underlying causes and may respond differently to treatment.
Broad claims that red light therapy "treats neuropathy" therefore go beyond what the current evidence can support.
What the Current Evidence Does Not Prove
The existing research does not prove that red light therapy can cure neuropathy.
It also does not establish that it can reverse all forms of nerve damage, replace medication, prevent neuropathy from progressing, or produce the same results with every home red light device.
Another limitation is the lack of standardized treatment protocols.
Different studies have used different wavelengths, light sources, treatment frequencies, exposure times, and energy doses. Some studies have also had relatively small sample sizes or short follow-up periods.
The 2024 systematic-review protocol on PBM for diabetic peripheral neuropathy specifically noted that although preliminary findings were promising, more evidence was needed to establish the safety and effectiveness of PBM and to clarify the most appropriate treatment protocols. Read the systematic review protocol
More large-scale randomized controlled trials with standardized protocols and longer follow-up are needed to determine which wavelengths and treatment doses are most effective and which types of neuropathy are most likely to respond.
How to Think About Red Light Therapy for Neuropathy
The most reasonable interpretation of the current research is neither "red light therapy does nothing" nor "red light therapy can repair damaged nerves."
The evidence falls somewhere in between.
Photobiomodulation has a plausible biological mechanism and an expanding body of clinical research. Studies, particularly those involving diabetic peripheral neuropathy, suggest that it may help reduce neuropathic pain and may improve certain measures of sensory or nerve function.
At the same time, the research is not strong enough to support broad claims about curing neuropathy or reversing established nerve damage.
For someone considering PBM, the most evidence-based approach is to view it as a potential complementary therapy while continuing to address the underlying cause of neuropathy and following established medical treatment.
The Bottom Line
Red light therapy for neuropathy is a promising area of research, but the science is not yet strong enough to call it a cure.
The best available evidence suggests that photobiomodulation may help some people with peripheral neuropathy, particularly with neuropathic pain. Some studies have also reported improvements in sensory measurements and indicators of nerve function.
However, studies differ considerably in their wavelengths, doses, treatment schedules, and devices. The long-term benefits are also not yet fully established.
If you are considering red light therapy, pay attention to the actual treatment specifications rather than simply choosing the device with the highest wattage or brightest LEDs. Wavelength, irradiance, treatment distance, treatment time, and total energy dose are much more useful when comparing devices.
For now, the most accurate conclusion is simple: red light therapy may have a role in managing some neuropathy symptoms, but it should be considered a complementary option rather than a proven treatment for reversing nerve damage.
